APA (7th ed.) Citation

Schab, A., Compadre, A., Drexler, R., Loeb, M., Rodriguez, K., Brill, J., . . . Mullen, M. M. (2025, July). Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer. The Journal of Clinical Investigation.

Chicago Style (17th ed.) Citation

Schab, Angela, et al. "Phospho-RPA2 Predicts Response to Platinum and PARP Inhibitors in Homologous Recombination–proficient Ovarian Cancer." The Journal of Clinical Investigation Jul. 2025.

MLA (9th ed.) Citation

Schab, Angela, et al. "Phospho-RPA2 Predicts Response to Platinum and PARP Inhibitors in Homologous Recombination–proficient Ovarian Cancer." The Journal of Clinical Investigation, Jul. 2025.